Improvement of cardiovascular risk factors in patients with type 2 diabetes after long-term continuous subcutaneous insulin infusion
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Noh, Yun-Hee | - |
dc.contributor.author | Lee, Se-Myung | - |
dc.contributor.author | Kim, Eun-Ju | - |
dc.contributor.author | Lee, Hyunil | - |
dc.contributor.author | Lee, Jun-Ho | - |
dc.contributor.author | Lee, Ju-Han | - |
dc.contributor.author | Park, So-Young | - |
dc.contributor.author | Koo, Ja-Hyun | - |
dc.contributor.author | Wang, Jun-Ho | - |
dc.contributor.author | Lim, In-Ja | - |
dc.contributor.author | Choi, Soo-Bong | - |
dc.date.available | 2019-05-30T04:41:58Z | - |
dc.date.issued | 2008-07 | - |
dc.identifier.issn | 1520-7552 | - |
dc.identifier.issn | 1520-7560 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/23706 | - |
dc.description.abstract | Background The effects of long-term continuous subcutaneous insulin infusion (CSII) on cardiovascular risk factors such as hyperglycaemia, dyslipidaemia, and proinflammatory cytokine levels have not been assessed so far in type 2 diabetes. Methods We analysed the levels of HbA(1c), serum lipids, tumor necrosis factor alpha (TNF-alpha), and interleukin 6 (IL-6) at 0, 2, and 30 weeks after CSII in 15 patients with type 2 diabetes (mean age, 53.3 =/- 10.1 years; disease duration, 9.4 =/- 5.3 years) without previous history of major cardiovascular events. Results At week 30, CSII significantly lowered HbA(1c) by 5.0 +/- 0.9% compared to baseline (7.9 +/- 1.9%, p < 0.001) and improved high-density lipoprotein cholesterol (HDLc; 1.09 +/- 0.16 at baseline vs 1.25 +/- 0.15 mmol/L at week 30; p < 0.05) and low-density lipoprotein cholesterol (LDLc)/HDLc ratios (2.8 +/- 1.4 at baseline vs 2.2 +/- 0.9 at week 30; p < 0.05). CSII also decreased the proportion of patients with dyslipidaemia at week 30. At baseline, TNF-alpha and IL-6 levels were up-regulated (2.65 +/- 4.04 and 2.82 +/- 1.81 pg/mL, respectively) compared to the normal control (p < 0.01 and p < 0.05, respectively); however, cytokine levels decreased significantly at week 30 (1.44 +/- 2.25 and 1.99 +/- 1.05 pg/mL, respectively; p = NS vs control). Conclusions Long-term CSII alone decreased cardiovascular risk factors in poorly controlled type 2 diabetes, suggesting that the synchronization of sufficient insulin peaks with meal ingestion and continuous pulsatile infusion of basal insulin corrects metabolic derangements. Copyright (C) 2008 John Wiley & Sons, Ltd. | - |
dc.format.extent | 8 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | JOHN WILEY & SONS LTD | - |
dc.title | Improvement of cardiovascular risk factors in patients with type 2 diabetes after long-term continuous subcutaneous insulin infusion | - |
dc.type | Article | - |
dc.identifier.doi | 10.1002/dmrr.849 | - |
dc.identifier.bibliographicCitation | DIABETES-METABOLISM RESEARCH AND REVIEWS, v.24, no.5, pp 384 - 391 | - |
dc.description.isOpenAccess | N | - |
dc.identifier.wosid | 000258585800006 | - |
dc.identifier.scopusid | 2-s2.0-49449103190 | - |
dc.citation.endPage | 391 | - |
dc.citation.number | 5 | - |
dc.citation.startPage | 384 | - |
dc.citation.title | DIABETES-METABOLISM RESEARCH AND REVIEWS | - |
dc.citation.volume | 24 | - |
dc.type.docType | Article | - |
dc.publisher.location | 미국 | - |
dc.subject.keywordAuthor | type 2 diabetes | - |
dc.subject.keywordAuthor | continuous subcutaneous insulin infusion (CSII) | - |
dc.subject.keywordAuthor | HbA(1c) | - |
dc.subject.keywordAuthor | dyslipidaemia | - |
dc.subject.keywordAuthor | proinflammatory cytokines | - |
dc.subject.keywordPlus | PLASMINOGEN-ACTIVATOR INHIBITOR-1 | - |
dc.subject.keywordPlus | NECROSIS-FACTOR-ALPHA | - |
dc.subject.keywordPlus | TREATMENT PANEL III | - |
dc.subject.keywordPlus | GLYCEMIC CONTROL | - |
dc.subject.keywordPlus | SECONDARY-FAILURE | - |
dc.subject.keywordPlus | BASAL INSULIN | - |
dc.subject.keywordPlus | BODY-WEIGHT | - |
dc.subject.keywordPlus | THERAPY | - |
dc.subject.keywordPlus | DISEASE | - |
dc.subject.keywordPlus | MELLITUS | - |
dc.relation.journalResearchArea | Endocrinology & Metabolism | - |
dc.relation.journalWebOfScienceCategory | Endocrinology & Metabolism | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
84, Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea (06974)02-820-6194
COPYRIGHT 2019 Chung-Ang University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.